Europe Prefilled Syringe Market Forecast to 2030 - Regional Analysis - by Type, Material, Design, Application, and Distribution Channel

List of Tables

The Europe prefilled syringe market was valued at US$ 1,992.22 million in 2022 and is expected to reach US$ 4,388.29 million by 2030; it is estimated to record a CAGR of 10.4% from 2022 to 2030.

Growing Adoption of Self-Injecting Parenteral Devices Fuels Europe Prefilled Syringe Market

Self-injecting parenteral devices are gaining popularity due to the ease of use and ability to improve patient outcomes. These devices are designed to allow patients to self-administer medications at home or on the go and do not require assistance from healthcare professionals. These self-injection devices can help patients manage their symptoms more effectively and improve their quality of life. Moreover, self-injecting devices offer several advantages over traditional injection methods, such as the reduced risk of needlestick injuries, improved medication adherence, and reduction in overall healthcare costs. They also provide patients with greater control over their treatment, enabling them to adjust dosages and timing according to their individual needs.

Further, pharmaceutical companies are increasingly investing in the development of self-injecting parenteral devices for prefilled syringes, and healthcare providers are encouraging their use as a part of a broader shift toward patient-centered care. With the ongoing advancements in technology and design, self-injecting devices will likely continue to gain popularity in the coming years.

Europe Prefilled Syringe Market Overview

The Europe prefilled syringes market is segmented into Germany, UK, France, Italy, Spain, and the Rest of Europe. The region is expected to hold the second largest position in terms of revenue and market share, driven by the rising prevalence of chronic disorders such as cardiovascular disorders, diabetes, cancer, and fertility issues and increased use of biosimilars available in prefilled syringes. Additionally, the growing trend of home healthcare and self-administration of drugs are expected to propel the prefilled syringes market growth. Furthermore, the increase in R&D activities, innovations, and new product launches will contribute to the prefilled syringes market expansion during 2022-2030.

Europe Prefilled Syringe Market Revenue and Forecast to 2030 (US$ Million)

Europe Prefilled Syringe Market Segmentation

The Europe prefilled syringe market is segmented based on type, material, design, application, distribution channel, and country.

Based on type, the Europe prefilled syringe market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger Europe prefilled syringe market share in 2022.

Based on material, the Europe prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger Europe prefilled syringe share in 2022.

Based on designs, the Europe prefilled syringe market is bifurcated into single chamber and multi chamber. The single chamber segment held a larger Europe prefilled syringe share in 2022.

In terms of application, the Europe prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. The others segment held the largest Europe prefilled syringe share in 2022.

By distribution channel, the Europe prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment held the largest Europe prefilled syringe market share in 2022.

Based on country, the Europe prefilled syringe market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe prefilled syringe market in 2022.

B Braun SE, Baxter International Inc, Becton Dickinson and Co, Delta Med SPA, Gerresheimer AG, Nipro Corp, Schott AG, Shandong Weigao Group Medical Polymer Co Ltd, Terumo Corp, and Ypsomed Holding AG are some of the leading companies operating in the Europe prefilled syringe market.

Product Code: BMIRE00029982

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Prefilled Syringe Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Chronic Disorders
- 4.1.2 Growing Adoption of Self-Injecting Parenteral Devices
4.2 Market Restraints
- 4.2.1 Increasing Product Recalls
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Ongoing Innovation in Prefilled Syringes
4.5 Impact Analysis

5. Prefilled Syringe Market - Europe Market Analysis

5.1 Europe Prefilled Syringe Market Revenue (US$ Mn), 2022 - 2030

6. Europe Prefilled Syringe Market - Revenue and Forecast to 2030 - by Type

6.1 Overview
6.2 Europe Prefilled Syringe Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Disposable Prefilled Syringes
- 6.3.1 Overview
- 6.3.2 Disposable Prefilled Syringes: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Reusable Prefilled Syringes
- 6.4.1 Overview
- 6.4.2 Reusable Prefilled Syringes: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Prefilled Syringe Market - Revenue and Forecast to 2030 - by Material

7.1 Overview
7.2 Europe Prefilled Syringe Market Revenue Share, by Material 2022 & 2030 (%)
7.3 Glass Prefilled Syringes
- 7.3.1 Overview
- 7.3.2 Glass Prefilled Syringes: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Plastic Prefilled Syringes
- 7.4.1 Overview
- 7.4.2 Plastic Prefilled Syringes: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Prefilled Syringe Market - Revenue and Forecast to 2030 - by Design

8.1 Overview
8.2 Europe Prefilled Syringe Market Revenue Share, by Design 2022 & 2030 (%)
8.3 Single Chamber
- 8.3.1 Overview
- 8.3.2 Single Chamber: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Multi-chamber
- 8.4.1 Overview
- 8.4.2 Multi-chamber: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Prefilled Syringe Market - Revenue and Forecast to 2030 - by Application

9.1 Overview
9.2 Europe Prefilled Syringe Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Cancer
- 9.3.1 Overview
- 9.3.2 Cancer: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diabetes
- 9.4.1 Overview
- 9.4.2 Diabetes: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Autoimmune Diseases
- 9.5.1 Overview
- 9.5.2 Autoimmune Diseases: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Infectious Diseases
- 9.6.1 Overview
- 9.6.2 Infectious Diseases: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Prefilled Syringe Market - Revenue and Forecast to 2030 - by Distribution Channel

10.1 Overview
10.2 Europe Prefilled Syringe Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
10.3 Hospital Pharmacies
- 10.3.1 Overview
- 10.3.2 Hospital Pharmacies: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Retail Pharmacies
- 10.4.1 Overview
- 10.4.2 Retail Pharmacies: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Online Channels
- 10.5.1 Overview
- 10.5.2 Online Channels: Europe Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Prefilled Syringe Market - Country Analysis

11.1 Europe Prefilled Syringes Market, Revenue and Forecast to 2030
- 11.1.1 Europe Prefilled Syringes Market, by Country
  - 11.1.1.1 UK
    - 11.1.1.1.1 Overview
    - 11.1.1.1.2 UK Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.1.3 UK: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
    - 11.1.1.1.4 UK: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
    - 11.1.1.1.5 UK: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
    - 11.1.1.1.6 UK: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
    - 11.1.1.1.7 UK: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 11.1.1.2 Germany
    - 11.1.1.2.1 Overview
    - 11.1.1.2.2 Germany Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.2.3 Germany: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
    - 11.1.1.2.4 Germany: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
    - 11.1.1.2.5 Germany: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
    - 11.1.1.2.6 Germany: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
    - 11.1.1.2.7 Germany: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 11.1.1.3 France
    - 11.1.1.3.1 Overview
    - 11.1.1.3.2 France Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.3.3 France: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
    - 11.1.1.3.4 France: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
    - 11.1.1.3.5 France: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
    - 11.1.1.3.6 France: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
    - 11.1.1.3.7 France: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 11.1.1.4 Italy
    - 11.1.1.4.1 Overview
    - 11.1.1.4.2 Italy Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.4.3 Italy: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
    - 11.1.1.4.4 Italy: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
    - 11.1.1.4.5 Italy: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
    - 11.1.1.4.6 Italy: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
    - 11.1.1.4.7 Italy: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 11.1.1.5 Spain
    - 11.1.1.5.1 Overview
    - 11.1.1.5.2 Spain Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.5.3 Spain: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
    - 11.1.1.5.4 Spain: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
    - 11.1.1.5.5 Spain: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
    - 11.1.1.5.6 Spain: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
    - 11.1.1.5.7 Spain: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 11.1.1.6 Rest of Europe
    - 11.1.1.6.1 Overview
    - 11.1.1.6.2 Rest of Europe Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.6.3 Rest of Europe: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
    - 11.1.1.6.4 Rest of Europe: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
    - 11.1.1.6.5 Rest of Europe: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
    - 11.1.1.6.6 Rest of Europe: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
    - 11.1.1.6.7 Rest of Europe: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)

12. Industry Landscape

12.1 Overview
12.2 Organic Developments
- 12.2.1 Overview
12.3 Inorganic Developments
- 12.3.1 Overview

13. Company Profiles

13.1 B Braun SE
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Delta Med SPA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Shandong Weigao Group Medical Polymer Co Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Gerresheimer AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Schott AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Nipro Corp
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Becton Dickinson and Co
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Baxter International Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Terumo Corp
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Ypsomed Holding AG
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms